JNJ and AMGN Related Headlines
Go Back- Amgen and Biogen 'look attractive' - HSBC
- Biden Administration lists 10 drugs subject to Medicare price negotiations
- HHS Names 10 Drugs Subject To Medicare Price Negotiations
- Amgen settles patent lawsuit over biosimilar of J&J's big-selling Stelara
- Amgen (AMGN) acquires Horizon (HZNP) for $26 billion as Sanofi (SNY) drops bid
- Sanofi shares rise after French drugmaker ditches Horizon deal talks
- Amgen (AMGN) in advanced talks to acquire Horizon Therapeutics (HZNP) - WSJ